Using RWD to Improve Clinical Trial Recruitment, Endpoints, and Inform Market Access Strategies
Stephanie Baum , 2025-05-16 11:30:00 Gaining greater insight into the patient journey from diagnosis through treatment is a priority for drug developers as they seek to produce more effective drugs. Using non-small cell lung cancer (NSCLC) as an example, PurpleLab and Genentech will explore how to leverage real world data (RWD) to eliminate blind spots in the…